Abstract

To estimate the prevalence of off-label drug use by age in children 12 years old and younger in Brazil. Population-based cross-sectional study (National Survey on Access, Use and Promotion of Rational Use of Medicines - PNAUM), including 7,528 children aged 12 years or younger. Face-to-face interviews were used to collect the data in the domiciles. The age-related off-label classification was carried out using the electronic medication compendium of National Agency of Sanitary Surveillance (ANVISA). Sociodemographic characteristics, presence of chronic disease, use of health services and characteristics of the informant were collected. Data were expressed by relative frequencies and 95% confidence intervals. Pearson's chi-square test was used to evaluate the statistical significance of the differences between the groups, with a significance level of 5%. Main outcome measure was the prevalence of off-label use. The prevalence of off-label use by age was 18.7% (95%CI 16.4 - 21.3). Children younger than 2 years old presented the highest prevalence of off-label use. The most frequently used off-label drugs by age were amoxicillin, nimesulide and the combination of phenylephrine and brompheniramine. The off-label use of drugs by age is common in the Brazilian pediatric population, especially among children under two years old.

Highlights

  • The age-related off-label classification was carried out using the electronic medication compendium of National Agency of Sanitary Surveillance (ANVISA)

  • Data were expressed by relative frequencies and 95% confidence intervals

  • Main outcome measure was the prevalence of off-label use

Read more

Summary

Introduction

Nos Estados Unidos, a prevalência de prescrição off-label segundo idade e indicação foi de 62% para indivíduos de 0 a 17 anos, de acordo com estudo realizado entre os anos de 2001 e 2004 com 7.901 crianças atendidas em consultórios médicos[11]. A classificação de cada medicamento quanto ao uso off-label segundo a idade foi realizada conforme a indicação de idade ou faixa etária registrada na bula, por meio de consulta à base de dados do Bulário Eletrônico[15], que disponibiliza, para consulta online, as bulas aprovadas pela ANVISA.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call